Cargando…

Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer

BACKGROUND: FOXM1 regulates expression of cell cycle related genes that are essential for progression into DNA replication and mitosis. Consistent with its role in proliferation, elevated expression of FOXM1 has been reported in a variety of human tumour entities. FOXM1 is a gene of interest because...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bektas, Nuran, Haaf, Anette ten, Veeck, Jürgen, Wild, Peter Johannes, Lüscher-Firzlaff, Juliane, Hartmann, Arndt, Knüchel, Ruth, Dahl, Edgar
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265720/ https://www.ncbi.nlm.nih.gov/pubmed/18254960 http://dx.doi.org/10.1186/1471-2407-8-42

Ejemplares similares

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer
por: Veeck, Jürgen, et al.
Publicado: (2008)

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours
por: Veeck, Jürgen, et al.
Publicado: (2008)

Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival
por: ten Haaf, Anette, et al.
Publicado: (2009)

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer
por: Veeck, Jürgen, et al.
Publicado: (2009)

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer
por: Bektas, Nuran, et al.
Publicado: (2008)

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer
por: Wiesmann, Frank, et al.
Publicado: (2009)

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer
por: Noetzel, Erik, et al.
Publicado: (2008)

Production and characterisation of monoclonal antibodies against RAI3 and its expression in human breast cancer
por: Jörißen, Hannah, et al.
Publicado: (2009)

Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: A systematic expression analysis
por: Hamm, Alexander, et al.
Publicado: (2008)

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
por: Kloten, Vera, et al.
Publicado: (2013)

Prognostic Significance of Forkhead Box M1 (FOXM1) Expression and Antitumor Effect of FOXM1 Inhibition in Angiosarcoma
por: Ito, Takamichi, et al.
Publicado: (2016)

Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
por: Verjans, Eva, et al.
Publicado: (2009)

Modes of Interaction of KMT2 Histone H3 Lysine 4 Methyltransferase/COMPASS Complexes with Chromatin
por: Bochyńska, Agnieszka, et al.
Publicado: (2018)

Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics
por: Tabnak, Peyman, et al.
Publicado: (2023)

Role and regulation of the forkhead transcription factors FOXO3a and FOXM1 in carcinogenesis and drug resistance
por: Gomes, Ana R., et al.
Publicado: (2013)

BDNF Is Associated with SFRP1 Expression in Luminal and Basal-Like Breast Cancer Cell Lines and Primary Breast Cancer Tissues: A Novel Role in Tumor Suppression?
por: Huth, Laura, et al.
Publicado: (2014)

Regulation of the MAD1 promoter by G-CSF
por: Jiang, Kan, et al.
Publicado: (2008)

Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer
por: Mijnes, Jolein, et al.
Publicado: (2018)

High expression of forkhead box M1 (FOXM1) is a poor prognostic biomarker in lung adenocarcinoma
por: Xiao, Hong, et al.
Publicado: (2020)

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
por: Sassen, Andrea, et al.
Publicado: (2008)

Endotoxin tolerance in mast cells, its consequences for IgE-mediated signalling, and the effects of BCL3 deficiency
por: Poplutz, Magdalena, et al.
Publicado: (2017)

Cytoplasmic Forkhead Box M1 (FoxM1) in Esophageal Squamous Cell Carcinoma Significantly Correlates with Pathological Disease Stage
por: Hui, Marco K. C., et al.
Publicado: (2011)

Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel
por: Li, Xiaoxiao, et al.
Publicado: (2013)

Overexpression of Forkhead Box Protein M1 (FOXM1) in Ovarian Cancer Correlates with Poor Patient Survival and Contributes to Paclitaxel Resistance
por: Zhao, Fung, et al.
Publicado: (2014)

Enhancer of the rudimentary gene homologue (ERH) expression pattern in sporadic human breast cancer and normal breast tissue
por: Zafrakas, Menelaos, et al.
Publicado: (2008)

Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis
por: Serce, Nuran Bektas, et al.
Publicado: (2012)

FoxM1, a Forkhead Transcription Factor Is a Master Cell Cycle Regulator for Mouse Mature T Cells but Not Double Positive Thymocytes
por: Xue, Ling, et al.
Publicado: (2010)

FOXM1 predicts disease progression in non-muscle invasive bladder cancer
por: Rinaldetti, Sebastien, et al.
Publicado: (2018)

The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
por: Bergamaschi, Anna, et al.
Publicado: (2014)

Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer
por: Lorsy, Eva, et al.
Publicado: (2016)

ING5 Is Phosphorylated by CDK2 and Controls Cell Proliferation Independently of p53
por: Linzen, Ulrike, et al.
Publicado: (2015)

AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection
por: Garczyk, Stefan, et al.
Publicado: (2015)

Epigenetic inactivation of ST6GAL1 in human bladder cancer
por: Antony, Pia, et al.
Publicado: (2014)

The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility
por: Pandithage, Ruwin, et al.
Publicado: (2008)

Hematopoietic stem and progenitor cell proliferation and differentiation requires the trithorax protein Ash2l
por: Lüscher-Firzlaff, Juliane, et al.
Publicado: (2019)

Induction of senescence upon loss of the Ash2l core subunit of H3K4 methyltransferase complexes
por: Bochyńska, Agnieszka, et al.
Publicado: (2022)

Loss of the Ash2l subunit of histone H3K4 methyltransferase complexes reduces chromatin accessibility at promoters
por: Barsoum, Mirna, et al.
Publicado: (2022)

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases
por: Zhang, Zhenwang, et al.
Publicado: (2023)

Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies
por: Zafrakas, Menelaos, et al.
Publicado: (2006)

ITIH5 mediates epigenetic reprogramming of breast cancer cells
por: Rose, Michael, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_m70k3tjt1pneqor2ptbqb0i38h